There is conflicting evidence regarding safety of digoxin. We aimed to evaluate the risk of mortality with digoxin use in. In all af patients, irrespective of heart failure status, digoxin is. Heart failure hf is the leading cause of hospitalization among older adults. Digoxin is indicated for the treatment of mild to moderate heart failure in adults. Effectiveness and safety of digoxin among contemporary. Prescribing information lanoxin digoxin tablets, usp. In the past three decades, with the greatest knowledge of the pathophysiology of the. Digoxin is the oldest cardiac drug still in contemporary use, yet its role in the management of patients with heart failure hf remains controversial. The majority of clinical trials published since 1980, most of which examined patients with new york heart association class u and in congestive heart failure, indicate that digoxin with or without reduces the.
In patients with atrial fibrillation af and heart failure hf, beta blockers and digoxin reduce the ventricular rate, but controversy exists concerning how these drugs affect prognosis in this. Digoxin discontinuation and outcomes in patients with. Digoxin is a medicine licensed to treat congestive heart failure and atrial fibrillation. The role of digoxin in the treatment of heart failure. Digoxin was approved for heart failure in 1998 under current. Digoxin is used to control ventricular rate in atrial fibrillation af. Digoxin can help slow an abnormal heart rhythm and strengthen the hearts contractions. Despite more than 200 years of clinical experience and a pivotal trial, digoxin, a purified cardiac glycoside derived from the foxglove plant, remains the most controversial drug in contemporary cardiovascular medicine.
However, despite established arrhythmic and nonarrhythmic toxicities, there are only limited, conflicting, and mostly older observational data on the safety of. Digoxin treatment in heart failure unveiling risk by. Digoxin appears to be of most benefit in patients with severe heart. But the line between an effective dose and a toxic one is. Objectives this study was developed to determine contemporary management of digoxin toxicity and clinical outcomes. Digoxin tablets, usp are indicated for the treatment of mild to moderate heart failure in adults. Digoxin therapy in acute heart failure springerlink.
As per accfaha guidelines, a loading dose to initiate digoxin therapy in patients with heart failure is not necessary. When combining death from any cause or hospitalization due worsening heart failure, the digoxin group had fewer events rr 0. Most frequently it is used for atrial fibrillation, atrial flutter, and heart failure. Digoxin tablets, usp increase left ventricular ejection fraction and. New concerns about an old heart drug the new york times. Update on digoxin therapy in congestive heart failure. The mechanism of digoxins lanoxin increase in inotropy.
The digitalis investigation group dig trial was a landmark randomized, doubleblind, placebo controlled multicenter trial on the effectiveness of digoxin in patients with. Despite more than 200 years of clinical experience and a pivotal trial, digoxin, a purified cardiac glycoside derived from. The related drug information index provides comprehensive access to all drug information related to a specific drug types of content include full prescribing information, drug summaries, full prescribing. The digitalis investigation group dig trial was a landmark randomized, doubleblind, placebo controlled multicenter trial on the effectiveness of digoxin in patients with congestive heart failure hf. Digoxin in heart failure and cardiac arrhythmias the. Cardiac glycoside an overview sciencedirect topics. Patients in the digoxin group, however, were significantly less likely to be hospitalized for worsening of heart failure. Digoxin has been shown to reduce hospitalization due to worsening hf. Digoxin use to control ventricular rate in patients with.
Digitalis, particularly digoxin, have played an important role in the treatment of heart failure hf for over 200 years. Sexbased differences in the effect of digoxin for the. Lanoxin, digox, digitek, cardoxin the following information is not intended to endorse any particular medication. Digoxin use in patients with heart failure with reduced ejection fraction. With 1 million hospitalizations each year, heart failure hf is the number 1 reason for hospital admission in patients. Background the deleterious effects of discontinuation of digoxin on outcomes in ambulatory patients with chronic heart failure hf with reduced ejection fraction hfref receiving angiotensinconverting enzyme inhibitors are welldocumented.
Pdf digoxin in heart failure and cardiac arrhythmias. The use of digoxin in patients with worsening chronic. Heart failure addon treatment in infants with reduced ejection fraction if. Contemporary use of digoxin in the management of cardiovascular. Digoxins roles in heart failure patients an overview. This prescription drug works by blocking a certain enzyme in the body, allowing the heart to be more efficient at. Digoxin may be useful for maintaining clinical stability and exercise capacity in patients with symptomatic heart failure. Digoxin in patients with atrial fibrillation and heart. Marked hf symptoms at rest recurrent hospitalizations despite gdmt. Recent randomised controlled trials in patients with chronic heart failure have reported that combining. Digoxin increases left ventricular ejection fraction and improves heart failure.
Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure. Background although the use of digoxin in heart failure management. Digoxin lanoxin is a well known cardiac glycoside and has been used for many years to treat several cardiovascular problems, such as heart failure and rate control in patients with atrial arrhythmias who. For purposes of antibody combining site structurefunction studies. Digoxin, sold under the brand name lanoxin among others, is a medication used to treat various heart conditions.
Heart transplant chronic inotropes temporary or permanent mcs experimental surgery or drugs palliative care and hospice icd deactivation refractory symptoms of hf at rest, despite gdmt at risk for heart failure heart failure e. The majority of clinical trials published since 1980, most of which examined patients with new york heart association class u and in congestive heart failure, indicate that digoxin with or without reduces the morbidity associated with congestive heart faitere, particularly m patients with more advanced symptoms and ven tricular dysiunction. The role of digoxin in the management of heart failure was clarified by a number of welldesigned randomised placebocontrolled clinical trials in the 1990s. Digoxin is one of the oldest drugs in cardiovascular medicine, and it was traditionally used in patients with atrial fibrillation af and heart failure hf. Acute setting for patients with hf and without accessory pathway.
Food and drug administration approved digoxin in 1997, the guidelines currently offer. The dig trial showed that although digoxin did not reduce overall mortality, it reduced admissions due to hf. Digoxin use to control ventricular rate in patients with atrial. If your prescription isnt listed, your pharmacist is the best source for more information. The majority of deaths attributable to heart failure occur in women, 6 even though women with heart failure have a lower risk of death than men. The effect of digoxin on mortality and morbidity in patients with heart failure. Atrial fibrillation, betablocker, digoxin, heart failure. Digoxin, a cardiac glycoside, exerts its positive inotropic effects by inhibiting the. The senior author of a new affirm analysis says the results should make doctors think hard about whether to prescribe digoxin for af patients, especially if they dont also have heart failure. Pdf background the role of cardiac glycosides in treating patients with chronic heart failure and normal sinus rhythm remains controversial. The effectiveness of digoxin in treating heart failure. Pdf digoxin in heart failure and cardiac arrhythmias researchgate. Current guidelines approve the use of digoxin in patients with heart failure with. Digoxin and reduction of heart failure hospitalization in.
In 1785, withering 5 recognized that the narrow therapeutictoxic dose ratio of cardiac. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. In patients with heart failure due to systolic dysfunction and af, digoxin cardiac arrhythmias due to digoxin toxicity view in chinese cardiac glycosides digitalis preparations including digoxin and. In addition, the related articles feature on pubmed was used and a manual search was. Digoxin should be used as a firstline drug in patients with congestive heart failure who are in atrial fibrillation. Digoxin is often used to treat symptoms of heart failure. Learn more from webmd about types of this medication, including its side effects and interaction with other drugs. The cost rises as the aging population rises and the lifetime cost after diagnosis of heart failure increases 6. Subgroup analysis showed that the benefit of digoxin on a combined outcome of. The use of digitalis glycosides in the management of acute heart failure remains controversial 14. Objectives the authors sought to determine the relationship between digoxin discontinuation and outcomes in hospitalized patients with hfref receiving. Digoxin for patients with atrial fibrillation and heart.
1511 1592 98 1154 1563 780 1527 1116 1323 1517 722 1112 1167 858 1592 378 79 1399 1140 986 1137 1552 1445 323 536 656 1245 1149 1524 1147 136 454 987 413 1028 1233 1333